Sangamo Therapeutics
SGMO
#10418
Rank
S$39.57 M
Marketcap
S$0.09551
Share price
0.00%
Change (1 day)
-84.75%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$34.55 Million. In 2025 the company made an earning of -S$0.14 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion1.61%
2025 -S$0.14 Billion9.71%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.26 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$99.59 Million36.89%
2017 -S$72.75 Million-22.32%
2016 -S$93.66 Million54.86%
2015 -S$60.48 Million75.62%
2014 -S$34.44 Million0.13%
2013 -S$34.4 Million
2011 -S$46.24 Million43.66%
2010 -S$32.19 Million28.52%
2009 -S$25.05 Million-23.55%
2008 -S$32.76 Million2.45%
2007 -S$31.98 Million19.5%
2006 -S$26.76 Million50.78%
2005 -S$17.75 Million75%
2004 -S$10.15 Million-33.25%
2003 -S$15.2 Million-62.27%
2002 -S$40.27 Million102.82%
2001 -S$19.86 Million23.21%
2000 -S$16.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.53 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.72 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.09 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$3.27 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$13.84 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.97 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.12 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA